Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.

OSLO, Norway, August 11, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the 'Healthcare Resource Utilization and Costs Associated with Blue Light Versus White Light Cystoscopy in Non-Muscle-Invasive Bladder Cancer: A Retrospective...